🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Hereditary Transthyretin-mediated (hATTR) Amyloidosis

Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program NCT05040373n/a7 sites📍 Iowa City📍 Nantes📍 Münster Alnylam Pharmaceuticals ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis) NCT04561518n/a40 sites📍 La Jolla📍 Los Angeles📍 Jacksonville Alnylam Pharmaceuticals Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis NCT06465810n/a89 sites📍 La Jolla📍 Los Angeles📍 San Francisco AstraZeneca · Tests: Treatment of transthyretin (ATTR) amyloidosis in observational study setting TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy NCT07223203Phase 361 sites📍 Aurora📍 Chicago📍 Baltimore Alnylam Pharmaceuticals · Tests: Nucresiran, Vutrisiran
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy